Intrinsiqq
Calidi Biotherapeutics Inc. logo

Calidi Biotherapeutics Inc. Insider Trading

CLDI

Compare
Last 12 months

Insiders sold 1K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Aug 2025.

Net open-market
−1K
0 buys · 1 sale
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 1
executives and directors
Last open-market buy
Aug 2025
Aug 21, 2025

Get an email when CLDI's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Dec 12, 2025No plan
    Allan Camaisa
    Director · sold 850 at $1.46
    1K
    1.1% of stake
  • Aug 21, 2025
    James A Schoeneck
    Director · bought 75,000 at $2.00
    150K
    788% of stake
  • Aug 21, 2025
    Eric E Poma
    Chief Executive Officer · bought 25,000 at $2.00
    50K
    New position
  • Aug 21, 2025
    Scott Leftwich
    Director · bought 125,000 at $2.00
    250K
    578% of stake
  • Aug 21, 2025
    Andrew C. Jackson
    Chief Financial Officer · bought 2,500 at $2.00
    5K
    New position
  • Dec 17, 2024No plan
    Allan Camaisa
    CEO and Chairman of the Board · sold 10,000 at $1.62
    16K
    13% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CLDI, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with CLDI

CompareIntrinsic value
INMBInmune Bio Inc.
$0.83-7.49%10
BCDABioCardia, Inc.
$0.79+2.60%26
ENZNViskase Holdings, Inc.
$4.35-1.14%0
SNTISenti Biosciences Inc.
$2.79-2.82%0
ALLOAllogene Therapeutics Inc.
$0.63-6.31%10
EXOZExozymes Inc.
$2.91-14.05%10
AIMAIM ImmunoTech Inc.
$0.11-4.50%25
CADLCandel Therapeutics Inc.
$5.04-1.75%10

Spot a number that looks wrong? Check it in CLDI's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing CLDI

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.